Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE) — Stella

Home/Overt Hepatic Encephalopathy/Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE)

View on ClinicalTrials.gov

Recruiting

Back to Overt Hepatic Encephalopathy trials

Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE)

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Department of Gastroenterology, General Hospital of Northern Theater Command (formerly called General Hospital of Shenyang Military Area), Shenyang, Liaoning

Key details

Sponsor

General Hospital of Shenyang Military Region

Enrollment target

~174 participants

Started

June 2025

Primary completion

June 2027

Age range

18 Years and older

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.